Stem cells in Leukemia and other hematological malignancies

Copland, M. , Michie, A. M. and Holyoake, T. L. (2009) Stem cells in Leukemia and other hematological malignancies. In: Majumder, S. (ed.) Stem Cells and Cancer. Springer New York: New York, NY, pp. 111-136. ISBN 9780387896106 (doi: 10.1007/978-0-387-89611-3_5)

Full text not currently available from Enlighten.

Publisher's URL:


Leukemia was the first malignant condition in which cancer stem cells were described. Leukemia stem cells (LSCs) have now been described in a number of different types of leukemia and are currently a major focus of research interest. LSCs are an important target for treatment of leukemia, and failure to eradicate these very primitive cancer cells is a common cause of leukemia relapse. Therefore, improved understanding of the biology of LSCs and the differences between normal hematopoietic and leukemic stem cells is likely to lead to the development of novel therapeutic strategies and improvements in leukemia therapy and patient survival.

Item Type:Book Sections
Glasgow Author(s) Enlighten ID:Michie, Professor Alison and Holyoake, Professor Tessa and Copland, Professor Mhairi
Authors: Copland, M., Michie, A. M., and Holyoake, T. L.
College/School:College of Medical Veterinary and Life Sciences > School of Cancer Sciences
Publisher:Springer New York

University Staff: Request a correction | Enlighten Editors: Update this record